1. Home
  2. KYNB vs ONMD Comparison

KYNB vs ONMD Comparison

Compare KYNB & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$5.99

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Logo OneMedNet Corp

ONMD

OneMedNet Corp

SELL

Current Price

$5.01

Market Cap

38.5M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
KYNB
ONMD
Founded
1993
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
38.5M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KYNB
ONMD
Price
$5.99
$5.01
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $39.67
N/A
AVG Volume (30 Days)
27.8K
★ 320.4K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 9552.08
83.33
EPS
N/A
★ N/A
Revenue
★ $6,440,000.00
$1,359,000.00
Revenue This Year
$4.23
N/A
Revenue Next Year
$14.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 111.35
52 Week Low
$5.62
$0.49
52 Week High
$9.58
$6.50

Technical Indicators

Market Signals
Indicator
KYNB
ONMD
Relative Strength Index (RSI) 21.99 83.48
Support Level N/A $0.68
Resistance Level $7.41 $6.50
Average True Range (ATR) 0.37 0.65
MACD -0.16 0.53
Stochastic Oscillator 14.38 75.78

Price Performance

Historical Comparison
KYNB
ONMD

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: